通过光学透射显微镜对组织微阵列(TMA)进行分形维数分析来检测癌症阶段
Detection of cancer stages through fractal dimension analysis of tissue microarrays (TMA) via optical transmission microscopy
摘要:
组织具有自相似的分形结构,其分形维数随着病变的发生而变化,如癌症等。利用透射显微镜对组织薄片进行光学成像可以产生与其折射率成比例的强度分布图案,其代表组织的质量密度分布图案。通过分析该质量密度分布来计算组织的分形维数,并且已知其随着癌变的进展而增加。本文探讨了使用分形维数分析的定量方法来创建标准化的准确癌症诊断测试和分期的可行性,从而减少了当前测试方法中存在的问题。大多数最致命的癌症的一个共同点是它们的致命性,这是由于在早期阶段或准确的晚期阶段难以正确诊断它们。这种困难可能是由于器官的物理位置导致它们难以接近,以及缺乏明显的症状,直到几乎没有治疗希望的晚期阶段。为了研究这些致命的癌症中的一些,分析了市售的石蜡包埋组织微阵列(TMA)样品,其包含胰腺癌、乳腺癌、结肠癌和前列腺癌的不同病例和阶段的多个核心。不同TMA样本的分形维数能够正确区分每种癌症的不同阶段,提高了创建标准化系统以提高未来诊断准确性的可能性。
英文摘要:
Tissues are fractal due to its self-similar structure, and the fractal dimension change with the abnormalities such as in disease like cancer. The optical imaging of thin slices of tissue using transmission microscopy can produce an intensity distribution pattern proportional to its refractive index which represents the mass density distribution pattern of the tissues. The fractal dimension of tissue is calculated by analyzing this mass density distribution and is known to increase with the progression of carcinogenesis. This paper explores the viability of using this quantitative approach of fractal dimension analysis to create a standardized accurate cancer diagnosis test and staging which reduces the issues plaguing current testing methods. A commonality for most of the deadliest cancers is their lethality due to the difficulty in properly diagnosing them in the early stages or accurate late staging. This difficulty can arise from the physical location of the organ causing them to be hard to access and the lack of noticeable symptoms until the late stages when there is almost no hope of treatment. To study some of these deadly cancers, commercially available paraffin embedded tissue microarray (TMA) samples containing multiple cores of different cases and stages of Pancreatic, Breast, Colon, and Prostate cancer are analyzed. The fractal dimension of different TMA samples is able to correctly differentiate between the different stages of each cancer, raising the possibility of a standardized system being created to increase diagnosis accuracy in the future.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。